chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient acted fine in the two hours after vaccination, received no pain medication. Suddenly began acting lethargic, in pain, breathing looked labored about three hours later. Ibuprofen was given. Then patient vomitted six times of substance (food), and twice more (bile). Then patient became dehydrated, barely responsive to her mother. Patient received fluids and anti-nausea medication in the ER and was sent home. She acted fine the next day.
This spontaneous report as received from a medical assistant refers to a 25 year old female patient with allergy to amoxicillin and no pertinent medical history. On 03-AUG-1999 and 03-NOV-1999, the patient was vaccinated with doses 1 and 2 of RECOMBIVAX HB intramuscular (dose was not reported) lot numbers reported as 0137J and 0904A respectively. The patient had never received the third dose. On 06-FEB-2013, the patient had B surface antigens drawn and the results were non-reactive. At the time of the report, outcome for the event was unknown. Additional information has been requested.
Initial report received on 07 December 2006 from a health care professional. A five year old male patient, with a history of asthma, and who was taking Albuterol and Claritin, had received a first dose, right deltoid injection of Fluzone, lot number U2239AA, on 20 September 2006. The route of administration was not reported. The patient was seen in the physicians office 29 days post immunization for his second Fluzone injection. The second dose was not given as the patient was noted to have a skin rash on his legs, arms, abdomen and had minor hematuria. The patient was diagnosed with Henoch Schonlein purpura and was hospitalized four days later, on 23 October 2006. The patient was treated with oral and IV antibiotics. He was hospitalized for two days. At the time of this report, the patient had recovered.
Moderna COVID-19 Vaccine EUA With my arm being covered I hadn't noticed the rash until today (10 days after the injection).  My arm had been sore, but today I noticed a rash and I noticed by arm being itchy since yesterday.
Information has been received from a registered nurse concerning a 29 year old female employee with multiple "seasonal" allergies (also reported as "possible" allergies) and "was on antibiotic treatment most of the time employed here" who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (dates not available). It was reported that the pt "states she has had all her required shots as a part of ...past employment." On 02/11/2003, the reporter indicated that a recent titer for measles was negative. Follow up info reported that a titer for rubeola was "equivocal". Unspecified medical attention was sought. No further information is expected.  The pt also had a negative titer for varicella post vaccination with varicella virus vaccine live (MSD) (WAES #0302USA01175).
No additional AE information provided; Nurse reported the patient was administered an improperly stored dose of PNEUMOVAX 23 on 10/17/2019; Information has been received from a nurse regarding a patient of unknown age and gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 17-OCT-2019, the patient was vaccinated with an improperly stored dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) injection, for prophylaxis, lot number S004548 with expiration date in 12-AUG-2020 (route of administration, strength and anatomical location not reported).  The pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) was stored at a temperature of 47.3 degrees Fahrenheit (°F) for the time frame of 20 minutes. There was no previous temperature excursion and the call was because of a data logger.   No additional adverse effects reported.  This is one of several cases from the same reporter. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: No; reasonfornoneval: 81 Other; reasonfornonevalother: No information about availability; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent; Sender's Comments:  US-009507513-2005USA000302:
Headache day after vaccine, Developed fever of 103.2 around noon on 3/19/21  3/20/21 The Fever and headache was completely gone
Administration error: A 42-year-old female patient receives a Pfizer 0.3ml vaccine as a second booster, a patient does not suffer from a condition that compromises the immune system, so he was not in the age category to receive his second booster dose.
Diarrhea; Nausea; Headache; Abdominal pain; Fever; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received first doe of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL9265), via an unspecified route of administration in left arm on 26Jan2021 at 11:00 (at the age of 52 years old) as single for covid-19 immunisation. Medical history included post-traumatic stress disorder from childhood, diabetes mellitus from 2000 to an unknown date, bipolar disorder from 2012 to an unknown date, anxiety, bipolar depression, thyroid disorder, preventative vascular problems, hypersensitivity, nightmare, sleep disorder. The family medical history included her brother was afraid to get the vaccine due to her symptoms. Concomitant medications included fluoxetine hydrochloride (PROZAC), 40mg; once daily by mouth, taking form years for bipolar depression; gabapentin 300mg; take one twice daily by mouth, taking form years for anxiety; aripiprazole (ABILIFY, reporter mentions before starting Abilify she used to take Rexulti. Provides NDC 5914803913; lot BNSO1620A and expiration date Jul2022), 15mg; take once daily by mouth for bipolar disorder from Dec2020 and ongoing; levothyroxine 137mcg; take once daily by mouth for thyroid disorder from 2014 and ongoing; simvastatin, 20mg; take once daily by mouth from several years for preventative vascular problems; levocetirizine, 5mg, take once daily by mouth for hypersensitivity from 2020 and ongoing; prazosin, 2mg; take two daily by mouth, taking form several years for nightmare; levocarnitine hydrochloride (LEVAMIN), 30 units daily by injection for diabetes mellitus from 2014 and ongoing; liraglutide (VICTOZA), 1.2mg; take once daily by injection for diabetes mellitus from Aug2020 and ongoing; eszopiclone 3mg; take once daily by mouth, taking form years for sleep disorder. The patient did not have history of previous immunization with the Pfizer vaccine considered as suspect. The patient did not administer any other vaccines on same date of the Pfizer suspect. The patient did not receive any other vaccines within 4 weeks. The patient didn't had illness at time of vaccination. On 26Jan2021, patient experienced fatigue. Three days later she noticed abdominal pain, nausea, headache and fever on 29Jan2021; diarrhea on 30Jan2021. Adds she went to her doctor who told her just to wait it out; to do symptom management; and to call Pfizer to report. She was asking if she should get the second shot? She was scheduled to receive the second dose of the vaccine on 23Feb2021. It was supposed to be 16Feb2021, but she changed it. No relevant tests were performed. The patient saw the primary care but no admission to hospital. The outcome of abdominal pain, diarrhea was recovering, nausea, fatigue was not recovered, fever was recovered on 01Feb2021, headache was recovered on 03Feb2021.  Follow-up attempts are completed. No further information is expected.
Persistent daily hives all over my body started appearing about 2 weeks after the third booster shot. They have not cleared for months and I was forced to get a steroid shot to calm them down, however they are reappearing. In addition I have been experiencing mental fogginess.
Breastfeeding mother. Two days after receiving first COVID-19 Moderna vaccine (Lot #044B21A), exclusively breast-fed 20-week old infant presented with blood in his otherwise regular (loose, light tan colored, normal paste-textured from breastfeeding) stool. First and only occurrence of this symptom. Blood in stool abated after one week. We mentioned this to our pediatrician, they had no suggestions.
Severe pain at injection site, and could not lift arm for whole night. Went to ER - had prescribe pain killer. Subsided after 2 days.
This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a adult female patient who received dTpa vaccine for prophylaxis. On an unknown date, the patient received dTpa vaccine. On an unknown date, unknown after receiving dTpa vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), whooping cough (serious criteria GSK medically significant), sickness and loss of voice. The patient was treated with IV Antibiotics (Nos) and Breathing Treatment (Medication Unknown). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the whooping cough, sickness and loss of voice were recovered/resolved. It was unknown if the reporter considered the vaccination failure, whooping cough, sickness and loss of voice to be related to dTpa vaccine. Additional information received as follows: The reporter was responding to a message on social media requesting she called GlaxoSmithKline concerning about whooping cough. The patient said that 15 years before reporting date, she received the DTAP but she did not know the brand. She had a case of whooping cough 6 years before reporting date. The patient was the first documented adult to had whooping cough in her county 6 years before reporting date. She was very sick for over 6 weeks. The patient was treated in the hospital. The patient lost her voice for 3 years from the severe coughing. The patient said that she found vaccine for this evidently was not effective as she found out later. She advised to cover mouth when cough and sneeze, wash hands and kept vaccines current. This would affect her breathing the rest of her life. This was nothing to fool with. This case was considered as a suspected vaccination failure case as the time to onset and the lab test confirmation for whooping cough were unknown. The patient did not consent to follow-up. Due to technical issues, the caller was lost so no additional information was provided. The patient's physician had since retired so she did not provide his name.
Severe systemic inflammatory response syndrome (SIRS) Pericardial Effusion Travel to Hospital emergence room by ambulance following 911 call. In emergency ward until late evening 3/6/21 Moved to intensive care area for 24 hours (3/6/21 to 3/7/21) Moved to regular ward in evening (3/6) or early morning (3/7). Tests showed low blood pressure at times, and a racing heart rate while resting. Released 3/9/21 - new medication: Colchicine and Benzonatate 06/18/2021 additional inflammatory response Dr.
Muscle pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Muscle pain). At the time of the report, MYALGIA (Muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Bicep is swollen; Definitely a bad reaction; Lymph node of neck (left side) is swollen; Lymph node of injection arm is swollen; Injection site is red; Injection site is swollen; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Bicep is swollen), VACCINATION COMPLICATION (Definitely a bad reaction), LYMPHADENOPATHY (Lymph node of neck (left side) is swollen), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE SWELLING (Injection site is swollen) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017E21A, 026L20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Aug-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE SWELLING (Injection site is swollen). On an unknown date, the patient experienced PERIPHERAL SWELLING (Bicep is swollen), VACCINATION COMPLICATION (Definitely a bad reaction), LYMPHADENOPATHY (Lymph node of neck (left side) is swollen) and VACCINATION SITE LYMPHADENOPATHY (Lymph node of injection arm is swollen). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of unknown; PARACETAMOL (TYLENOL) at a dose of unknown; IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of Unknown; CORTISONE ACETATE at a dose of Unknown; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at a dose of Unknown and NAPROXEN SODIUM (ALEVE) at a dose of unknown. At the time of the report, PERIPHERAL SWELLING (Bicep is swollen), VACCINATION COMPLICATION (Definitely a bad reaction), LYMPHADENOPATHY (Lymph node of neck (left side) is swollen), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site is swollen) and VACCINATION SITE LYMPHADENOPATHY (Lymph node of injection arm is swollen) outcome was unknown.            Patient thought to be used arthritis cream as treatment medication. No concomitant medications were reported.
I had an upcoming surgery, and I was not sleep well because I was worried about that. I was very fatigued and not sleeping well. But I started to notice that I was having problems walking my normal areas where I am going up and down hills and have no problems, but I was hardly able to do my walk and was just out of breath and fatigued. I had my surgery, and it all went well but then a few days later I was really in bad shape. I was having a problem breathing and horrible chest pain- I thought I may be having a heart attack. I was taken to the ER, and they tested my Tretinoin levels, and they did not indicate that I had a heart attack. Each test they did the number was not indicative of a heart attack, but the second test was a higher number but also not showing a heart attack the first was in the 50's and the second was close 100. The cardiologist wanted to do a third test and that was very high 1500, and it showed I was having a heart attack, but I was doing better and was not in pain and was feeling better, but this led them to act emergently. We tested my heart and all that and it was showing that everything was fine. I was diagnosed with Pleurisy which is fluid around the lungs. I went home and was back two days later with the same pains and issues. They did more heart testing and it showed Pericarditis. I was in the hospital for a few days but then went home. At the first hospital visit I did not have a correlation to my COVID-19 vaccine. I was put on new meds and some of my medications were changed due to the new medications. I ended up back in the hospital with more issues related to the Pericarditis. This was at first was thought it was irritation to the breathing tube from surgery that caused Pleurisy but then the second time I was in the hospital a team came to me to figure out what could be going on and they saw that I had my COVID-19 vaccine, and they stated this is a rare thing, but it can occur from having a COVID-19 vaccine. I did have more than one time I was in hospital and the total amount of days was about 12. I would not say I have recovered at this point because I did go off the medications that I was on for this new issue and that put me back into the hospital and I am now back on that medication and have been advised not to get any other COVID-19 vaccines. I am also seeing a doctor with the infectious disease department who is the same team that stated this was connected to my vaccine and he had been working with my cardiologist and I will be getting antibodies by an infusion rather than the vaccine under his care and monitoring.
mom phones nurse 21JUL93 to describe events of head pain & temp 102-105 @ 2AM; quiet w/no appetite; vomited & sent home from preschool;
I started to feel bad at about 8:10 pm and I received the first round of the vaccine about 4 hours prior (4:07). I started to itch and thought it was just dry skin. Then about 20 minutes later I started to get mild hives. I took Benadryl and that calmed it down. When I woke up the next day the itching went away and I just felt pretty fatigued throughout the day.
This spontaneous report as received from a other licensed nurse practitioner refers to unspecified number of patients of unknown age and gender. The patients' medical history, current conditions and concomitant medications were not reported. On an unknown date the patient was vaccinated with improperly stored dose of VARIVAX lot # M017290, expiry date: 07-APR-2018 and lot # M027343, expiry date: 01-JUN-2018 (dose and route were not reported). The details of the storage were temperature excursions of -12.4 C for 22 hours, 29 minutes, -12.5 C for 13 hours 26 minutes, -10.2 C for 19 hours 45 minutes and -10.6 C for 4 hours 11 minutes. No adverse events were reported. There was no product quality complaint involved. This is one of the two reports from the same reporter. Additional information is not expected as the physician cannot be contacted.
She reported that a child may have received VAQTA too early; She reported that a child may have received VAQTA too early; This spontaneous report was received from a consumer and refers to a child patient of unknown age. No information regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided.  On an unknown date, the patient may have received vaccinated with hepatitis a vaccine, inactivated (VAQTA) (formulation, dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis (product administered to patient of inappropriate age and circumstance or information capable of leading to medication error). No additional information was available.
Muscle aches; Fever; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EV0162) via an unspecified route of administration in the left arm on 08Apr2021 at 10:45 at the age of 37-years-old as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 18Mar2021 at 10:45 at the age of 36-years-old as a single dose for COVID-19 immunisation. On 08Apr2021 at 22:00, the patient experienced muscle aches, fever, and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle aches, fever, and headache was resolved on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a 5 year old patient who on 07-AUG-2008 was inadvertently vaccinated with ZOSTAVAX vaccine (Oka/Merck) (lot # 659409/0899X), 0.5 mL, subcutaneously, instead of the second dose of VARIVAX vaccine (Oka/Merck). No adverse experience noted. The patient sought at the office medical attention. Additional information has been requested.
745pm, after shot, Jan 18th, i felt tingling in legs and arms, by 9pm i felt very agitated, & uncomfortable. I started getting redness on my forearms and the itching began.  I called health care provider & saw them on Tues, i believe.  I was told to get OTC allergy meds. Itching continued. I was also told if itching continued i would be prescribed steroids.  On Thursday,  i was in so much distress, i couldn't not go to work.  I then saw Dr., he prescribed prednisone.
pt recvd vax & 2 days p/vax pt exp fever 104, restlessness, swollen glands & pharyngitis; dx w/lymphadenopathy;
3/5/21 Body Aches 3/4/21 Headache 3/4/21 Nausea 3/5/21 Chills
Pt recvd 2 doses of Engerix-B & exp elevated liver enyzmes; Also, has seen MD because pt is not feeling well;
Pt    had  reaction with first vaccine.  currently sees a cardiologist and neurologist. c/o sob.   50 mg po  bendaryl suspension given in divided dose.  VVS.   wife picked up pt.  monitored  pt for 60 minutes.
CHILLS; NAUSEA; FEVER; HEADACHE; This spontaneous report received from a parent concerned a 25 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced chills, nausea, fever, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nausea, fever, headache and chills was not reported. This report was non-serious.
HEADACHE; FEVER OF 101.7; ARM PAIN WHICH FEELS NERVE DAMAGE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 2021, the subject experienced headache. On 2021, the subject experienced fever of 101.7. On 2021, the subject experienced arm pain which feels nerve damage.  On 11-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 101.7 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, fever of 101.7 and arm pain which feels nerve damage was not reported. This report was non-serious.